Search Ontology:
ChEBI
ritlecitinib tosylate
- Term ID
- CHEBI:229234
- Synonyms
-
- 1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)piperidin-1-yl]prop-2-en-1-one 4-methylbenzenesulfonate (1:1)
- 1-{(2S,5R)-2-methyl-5-[(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}prop-2-en-1-one 4 methylbenzene-1-sulfonic acid
- 4-methylbenzene-1-sulfonic acid--1-{(2S,5R)-2-methyl-5-[(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}prop-2-en-1-one (1/1)
- Litfulo
- PF-06651600 tosylate
- ritlecitinib tosilate
- Definition
- An organosulfonate salt obtained by combining equimolar amounts of ritlecitinib and 4-toluenesulfonic acid. It is a kinase inhibitor, developed by Pfizer for the treatment of severe alopecia areata in adults and adolescents 12 years and older.
- References
-
- CAS:2192215-81-7
- DrugBank:DBSALT003482
- KEGG:D11970
- PMID:37556041
- PMID:37703124
- PMID:37983117
- PMID:38051245
- PMID:38051803
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_part
-
- has_role
-
Phenotype
Phenotype resulting from ritlecitinib tosylate
Phenotype where environments contain ritlecitinib tosylate
Phenotype modified by environments containing ritlecitinib tosylate
Human Disease / Model Data